Working… Menu

A Study of Pembrolizumab for Patients With Thymic Epithelial Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02607631
Recruitment Status : Completed
First Posted : November 18, 2015
Last Update Posted : July 9, 2020
Information provided by (Responsible Party):
Myung-Ju Ahn, Samsung Medical Center